Financial movements in the AI ecosystem, including venture capital investments, strategic acquisitions, IPO's and funding rounds for AI companies.
Legal AI startup Harvey has secured $150 million in new funding led by Andreessen Horowitz, pushing its valuation to $8 billion. This follows its €50 million investment from EQT Growth earlier this month as the company continues rapid expansion in the legal tech sector.
Burkhan Capital LLC is leading a $300 million investment in Robo.ai to expand its global AI and smart device platform, with the deal expected to close within 30 days.
Summer Robotics has completed the first closing of its Series A funding round led by Applied Ventures, LLC, with participation from Solasta Ventures, Naver, and others. The company also appointed Rick Van Valkenburg as Chief Commercial Officer to drive commercial growth.
Assistive Technology Development, Inc. (ATDev) has raised $3 million in seed funding led by Dobrzelecki Legacy Ventures, with participation from Uphonest Capital, The Life Science Angels, and other investors, to scale its AI-enabled mobility solutions.
The Bot Company, co-founded by former Cruise CEO Kyle Vogt, is reportedly seeking $250 million in new funding that would value the robotics startup at more than $4 billion.
Generation Lab has raised $11 million in seed funding led by Accel to expand its SystemAge platform, which measures biological aging across 19 organ systems using blood data.
Fourier Health has secured $8.4 million in seed funding led by Yosemite to advance its clinician-in-the-loop AI platform designed to simplify unstructured patient data and reduce administrative workload in healthcare.
Novartis has agreed to acquire Avidity Biosciences for approximately $12 billion in cash, with the deal expected to close in the first half of 2026 following the planned separation of Avidity’s early-stage cardiology programs into a new company called SpinCo.
Opyn Health has acquired Empara, an AI-driven benefits engagement and administration platform, to create a unified, end-to-end benefits solution for self-funded health plans.
Sage Care has launched from stealth with $20 million in funding led by Yosemite, joined by General Catalyst, Metrodora, and others. The company’s AI-driven platform streamlines healthcare operations through intelligent triage, scheduling, and patient-provider matching.
InnerScope Hearing Technologies has announced a strategic alliance with Ainnova Tech as part of Ainnova's acquisition of OTCHealth Inc., transitioning retail operations to the new subsidiary and focusing on global R&D and hearing technology innovation.
Honey Health has secured $7.8 million in seed funding led by Pelion Ventures to expand its AI platform that automates back-office workflows for healthcare organizations.
OpenAI has finalized its recapitalization, creating a new corporate structure where the nonprofit OpenAI Foundation holds control over the for-profit OpenAI Group. Microsoft retains a 27% stake, and the Foundation will use its equity to fund philanthropic initiatives in health and AI resilience.
Mem0 has raised $24 million in seed and Series A funding led by Basis Set Ventures to develop a memory infrastructure for AI agents that enables persistent recall across applications.
Moberg Analytics has secured $600,000 in seed funding to accelerate commercialization of its Moberg Clinical Platform, a software system that integrates multimodal brain data for intensive care units.
ROLLER has secured $50 million in funding led by Insight Partners, with participation from J.P. Morgan, to enhance its AI-powered venue management platform and expand its financial services offerings.
Palo Alto-based Spacial has raised $10 million in seed funding led by TLV Partners to advance its AI platform that automates engineering and permitting for residential construction projects across the U.S.
AI startup Mercor has raised $350 million in a Series C funding round led by Felicis, bringing its valuation to $10 billion. The company connects domain experts with AI labs to train foundational models and plans to expand its talent network and automation systems.
Northwest Biotherapeutics has finalized its acquisition of Advent BioServices, making it a wholly owned subsidiary. The deal includes all Advent assets and intellectual property, with payments to be made over two years.
Sensor Tower announced a strategic investment from Shinhan Securities to accelerate product innovation and expand its Generative AI and web data capabilities. The funding will support Sensor Tower’s continued growth following recent acquisitions and new product launches.
